|
|
Post by Clement on Jan 3, 2019 9:59:18 GMT -5
My prediction for CC tomorrow:
1. Mike says UTHR projects are on track*.
2. Mike says Technosphere non-UTHR projects are on track.
3. Mike says he will spend tens of millions on Afrezza promotion in 2019.
*In 2019, this could be $30 million for progress with "undisclosed molecule" + $25 million milestone with TreT + $40 million if another PAH molecule. These possible moneys have all been previously mentioned by Mike.
|
|
|
|
Post by kite on Jan 3, 2019 10:06:48 GMT -5
My prediction for CC tomorrow: 1. Mike says UTHR projects are on track*. 2. Mike says Technosphere non-UTHR projects are on track. 3. Mike says he will spend tens of millions on Afrezza promotion in 2019. *In 2019, this could be $30 million for progress with "undisclosed molecule" + $25 million milestone with TreT + $40 million if another PAH molecule. These possible moneys have all been previously mentioned by Mike. I don't want a rehash. I want to hear new developments. |
|
|
|
Post by boca1girl on Jan 3, 2019 10:09:26 GMT -5
My prediction for CC tomorrow: 1. Mike says UTHR projects are on track*. 2. Mike says Technosphere non-UTHR projects are on track. 3. Mike says he will spend tens of millions on Afrezza promotion in 2019. *In 2019, this could be $30 million for progress with "undisclosed molecule" + $25 million milestone with TreT + $40 million if another PAH molecule. These possible moneys have all been previously mentioned by Mike. Regarding #2: Which non-UTHR projects are you referring to? |
|
|
|
Post by Clement on Jan 3, 2019 10:19:53 GMT -5
My prediction for CC tomorrow: 1. Mike says UTHR projects are on track*. 2. Mike says Technosphere non-UTHR projects are on track. 3. Mike says he will spend tens of millions on Afrezza promotion in 2019. *In 2019, this could be $30 million for progress with "undisclosed molecule" + $25 million milestone with TreT + $40 million if another PAH molecule. These possible moneys have all been previously mentioned by Mike. Regarding #2: Which non-UTHR projects are you referring to? Remember the "4 additional molecules" that Mike talked about? ... from the buckets? There was a lot of speculation on this board about what they might be. |
|
|
|
Post by #NoMoreNeedles on Jan 3, 2019 10:24:31 GMT -5
Bucket 2: - Glucagon
- Rizatriptan
- Sumatriptan
- Palonosetron
- Oxytocin
Sumatriptan looks most exciting as it treats migraine
|
|
|
|
Post by lakon on Jan 3, 2019 10:29:21 GMT -5
#2: RLS should be moving forward as the legal obstacles are overcome. Brazil, India, ROW, ...
#4: Mike says he will need shareholders to loosen their belts and prepare to swallow another 100 million of authorized shares to protect against a hostile takeover, but little to no dilution is expected at this time (however, if you read the fine print, things could be different around the holidays late this year, just like last year so YMMV).
#5: Cheers and Happy New Year!
|
|
|
|
Post by lakon on Jan 3, 2019 10:32:20 GMT -5
Bucket 2: - Glucagon
- Rizatriptan
- Sumatriptan
- Palonosetron
- Oxytocin
Sumatriptan looks most exciting as it treats migraine
I do not know about you, but Oxytocin looks to be THE MOST exciting if you know what I MEAN... (Maybe the ladies can attest.) |
|
|
|
Post by boca1girl on Jan 3, 2019 10:40:25 GMT -5
#2: RLS should be moving forward as the legal obstacles are overcome. Brazil, India, ROW, ... #4: Mike says he will need shareholders to loosen their belts and prepare to swallow another 100 million of authorized shares to protect against a hostile takeover, but little to no dilution is expected at this time (however, if you read the fine print, things could be different around the holidays late this year, just like last year so YMMV). #5: Cheers and Happy New Year! I hate to think what would happen to the stock price if he announced the need for 100M more shares. |
|
|
|
Post by #NoMoreNeedles on Jan 3, 2019 10:40:29 GMT -5
LOL  |
|
|
|
Post by Clement on Jan 3, 2019 10:44:37 GMT -5
My prediction for CC tomorrow: 1. Mike says UTHR projects are on track*. 2. Mike says Technosphere non-UTHR projects are on track. 3. Mike says he will spend tens of millions on Afrezza promotion in 2019. *In 2019, this could be $30 million for progress with "undisclosed molecule" + $25 million milestone with TreT + $40 million if another PAH molecule. These possible moneys have all been previously mentioned by Mike. I don't want a rehash. I want to hear new developments. I think this would be a very positive rehash, especially the $95 million in #1 *. |
|
|
|
Post by lakon on Jan 3, 2019 10:47:14 GMT -5
#2: RLS should be moving forward as the legal obstacles are overcome. Brazil, India, ROW, ... #4: Mike says he will need shareholders to loosen their belts and prepare to swallow another 100 million of authorized shares to protect against a hostile takeover, but little to no dilution is expected at this time (however, if you read the fine print, things could be different around the holidays late this year, just like last year so YMMV). #5: Cheers and Happy New Year! I hate to think what would happen to the stock price if he announced the need for 100M more shares. I love it, but I may be a sadist and a masochist. |
|
|
|
Post by #NoMoreNeedles on Jan 3, 2019 11:26:07 GMT -5
Well, probably approx. 75 cents or less
|
|
|
|
Post by mango on Jan 3, 2019 11:38:15 GMT -5
this thread has a nice balance of depressing and exciting speculation.
|
|
|
|
Post by ktim on Jan 3, 2019 12:46:52 GMT -5
Well, probably approx. 75 cents or less Before or after announcing another Rev Split? |
|
|
|
Post by #NoMoreNeedles on Jan 3, 2019 12:52:06 GMT -5
Before of course. 75 cents would then automatically force another R/S
|
|
